CareDx, Inc. (CDNA) vs OPKO Health, Inc. (OPK)
- CareDx, Inc. CDNA 63.81 −4.30%
- OPKO Health, Inc. OPK 1.53 −4.97%
CareDx, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $3.5B against $1.2B — 2.9× the size. OPKO Health, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.7×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against −11.5%. CareDx, Inc. has the higher net margin (24.2% vs −12.4%) and the higher return on invested capital (130.1% vs −2.45%). Across the 19 metrics below, CareDx, Inc. leads on 15 and OPKO Health, Inc. on 4.
Valuation
Profitability
| Metric | CDNA | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | 40.77% | 50.89% |
| Operating margin | 23.61% | (8.21%) | (8.57%) |
| Net margin | 24.23% | (12.40%) | (6.37%) |
| Free cash flow margin | 18.49% | (22.75%) | 0.00% |
| Return on equity | 29.49% | (5.88%) | (2.92%) |
| Return on assets | 22.72% | (3.83%) | (6.71%) |
| Return on invested capital | 130.06% | (2.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack